BREA, Calif., Sept. 4, 2019 /PRNewswire/ — Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced it has launched a roadshow for the initial public offering (IPO) of its common stock. Envista is offering 26,768,000 shares of its common stock in the IPO. The underwriters will also have a 30-day option to purchase... Read more
Aug 15, 2019 Long, high-yield oligos with industry-beating low error rate enable researchers to skip amplification steps and start projects immediately CORALVILLE, IA (August 15, 2019) – Continuing its mission to advance biological research worldwide, Integrated DNA Technologies (IDT) has launched oPools™ Oligo Pools – ready-to-use pools of high quality DNA oligonucleotides (oligos) up to 350 nucleotides in length. Thanks... Read more
WASHINGTON, July 18, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2019. For the quarter ended June 28, 2019, net earnings were $731.3 million, or $0.97 per diluted share which represents a 2.0% year-over-year increase from the comparable 2018 period. Non-GAAP adjusted diluted net earnings per share were $1.19 which... Read more
WASHINGTON, June 27, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) today announced that Envista Holdings Corporation (“Envista” or the “Company”) will be the name of the separate company Danaher intends to create and take public via an initial public offering in the second half of 2019. Envista will be comprised of three operating companies within... Read more
WASHINGTON, June 18, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2019 on Thursday, July 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more
WASHINGTON, April 18, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2019. For the quarter ended March 29, 2019, net earnings were $333.8 million, or $0.46 per diluted share which represents a 41.0% year-over-year decrease from the comparable 2018 period. Non-GAAP adjusted diluted net earnings per share were $1.07 which... Read more
WASHINGTON, March 19, 2019 /PRNewswire/ –Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2019 on Thursday, April 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more
Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering WASHINGTON, March 1, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that it has closed concurrent offerings of 12,100,000 shares of common stock at a price to the public of $123.00 per share and 1,650,000 shares of 4.75% Series A Mandatory Convertible Preferred... Read more
Danaher Announces Plan To Spin Off Dental Business Into An Independent, Publicly Traded Company WASHINGTON, July 19, 2018 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced its intention to spin off its Dental segment into an independent, publicly-traded company (“DentalCo”). The transaction is intended to be tax-free to Danaher shareholders and expected to be completed... Read more
By partnering with WCRF, SCIEX supports research that benefits cancer patients July 12, 2018 Framingham, MA — SCIEX, a global leader in life science analytical technologies, has donated US$17,500 (£12,613.21 GBP) to World Cancer Research Fund (WCRF). A donation of US$11,000 was made as the result of 98% participation in the annual SCIEX employee engagement survey, where SCIEX... Read more